The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections
Rodriguez, W.J.; Wiedermann, B.L.
Advances in Pediatric Infectious Diseases 9: 125-159
1994
ISSN/ISBN: 0884-9404 PMID: 8123221 Document Number: 435031
Document emailed within 1 workday
Related Documents
Paul, K.; De, P.K.; Bhattacharya, S. 1992: Comparative efficacy of fluoroquinolones, aminoglycosides, ureidopenicillins and newer cephalosporins against Pseudomonas species Indian Journal of Medical Research 95: 136-138Vellend, H. 1989: Role of fluoroquinolones in lower respiratory tract infections Clinical and Investigative Medicine. Medecine Clinique et Experimentale 12(1): 39-43
Weiss, G.G. 2006: The role of fluoroquinolones in the management of skin, soft tissue, and bone infections Medical Economics 83(19): 34-37
Smith, D.L. 1975: The newer cephalosporins Missouri Medicine 72(4): 192-193
O'Callaghan, C.H. 1984: Properties of some of the newer cephalosporins Medical Laboratory Sciences 41(3): 279-284
Bergogne-Berezin, E. 1988: Oral cephalosporins. Role of cefuroxime-axetil Therapie 43(Suppl 4): 343-349
Ennis, D.M.; Cobbs, C.G. 1995: The newer cephalosporins. Aztreonam and imipenem Infectious Disease Clinics of North America 9(3): 687-713
Labro, M.; Bryskier, A. 1987: Immunomodulating properties of newer cephalosporins: a preliminary classification Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 219-221
Bochet, M.él.; Garin, N.; Janssens, J.-P.; Gerstel, E. 2011: Is there a role for prophylactic antibiotic treatment with macrolides in bronchiectasis? Revue Medicale Suisse 7(280): 308; 310-312
Gulati, P.D.; Agarwal, D.S.; Baweja, U.; Sethi, K.; Geeta, V. 1977: A newer cephalosporin (cephradine) in the treatment of urinary tract infections Journal of the Association of Physicians of India 25(4): 249-254
Dvoretskiĭ, L.I.; Omel'ianovskiĭ, V.V. 1998: Differential use of cephalosporins in treatment of upper and lower respiratory tract infections Antibiotiki i Khimioterapiia 43(6): 24-28
Acar, J.F. 1971: The use of cephalosporins in the treatment of urinary tract infections in adults due to Gram-negative organisms Postgraduate Medical Journal 47(Suppl): 103-107
Nikolaidis, P. 1990: Newer quinolones in the treatment of continuous ambulatory peritoneal dialysis (CAPD) related infections Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 10(2): 127-133
Rolin, O.; Bouanchaud, D.H. 1989: Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus Pathologie-Biologie 37(5): 375-377
Bertrand, A.; Janbon, F.; Jonquet, O.; Reynes, J. 1988: Rickettsiaceae infections and fluoroquinolones Pathologie-Biologie 36(5): 493-495
Alonso Manzanares, M.A.; Gutíerrez Zufiaurre, M.N.; Muñoz Bellido, J.L.; García-Rodríguez, J.A. 1998: Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae Medicina Clinica 110 Suppl. 1: 25-30
Guay, D.R. 1992: The role of the fluoroquinolones PharmacoTherapy 12(6 Part 2): 71s-85s
Kujala, P. 1999: Use of oral cephalosporins Duodecim; Laaketieteellinen Aikakauskirja 115(20): 2241-2247
Nightingale, C. 1980: Pharmacokinetics of the oral cephalosporins in adults Journal of International Medical Research 8(Suppl 1): 2-8
Goldzieher, J.W. 1964: Newer Drugs in Oral Contraception Medical Clinics of North America 48: 529-545